搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
同花顺股票频道
14 天
贝达药业:RGB-5088胰岛细胞注射液处于临床研究阶段
公司回答表示:公司战略合作伙伴杭州瑞普晨创科技有限公司自主研发的RGB-5088胰岛细胞注射液的临床试验申请已于2024年12月获国家药品监督管理局批准,目前处于临床研究阶段。有关RGB-5088胰岛细胞注射液的临床研究进展情况,您可以关注瑞普晨创官方网站的 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Agrees to policy changes
To resume some flights
Charged with capital murder
Woman drowned her dog
Offers $100 to WI voters
Trump rescinds order
Large-capacity ban upheld
Signs critical mineral order
US agency kills CO wolf
Cuts $580 million in funding
Nearly departs from taxiway
‘Vice Squad’ actor dies
Baseball card sells for $1M+
NYC jury finds 2 guilty
Brunson files for divorce
Minnesota senator resigns
Awards fighter jet contract
Australian tourist killed
UAE to invest $1.4T in US
US Treasury lifts sanctions
UCLA sued over attack
SBA to cut workforce
Toronto plane crash report
68 bridges need assessment
RU drones strike UKR city
Plans to invest $55B+ in US
NY congestion deadline
Scores 888th career goal
Sued over false advertising
Texas measles cases rise
Giants sign Humphrey
1st NCAA Tournament win
US sells rockets to Saudi
反馈